COYA

Coya Therapeutics (COYA)

Coya Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:COYA

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/28	21:15	Business Wire	Coya Therapeutics Announces Inclusion in the MSCI USA Micro Cap Index	NASDAQ:COYA	Coya Therapeutics Inc
2024/05/22	21:15	Business Wire	Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer’s Disease	NASDAQ:COYA	Coya Therapeutics Inc
2024/05/21	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COYA	Coya Therapeutics Inc
2024/05/20	21:15	Business Wire	Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)	NASDAQ:COYA	Coya Therapeutics Inc
2024/05/10	05:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:COYA	Coya Therapeutics Inc
2024/05/10	05:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COYA	Coya Therapeutics Inc
2024/05/10	05:10	Business Wire	Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results	NASDAQ:COYA	Coya Therapeutics Inc
2024/05/09	06:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COYA	Coya Therapeutics Inc
2024/04/26	21:15	Business Wire	Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium	NASDAQ:COYA	Coya Therapeutics Inc
2024/04/22	21:15	Business Wire	Coya Therapeutics to Participate in the Mizuho Neuroscience Summit	NASDAQ:COYA	Coya Therapeutics Inc
2024/04/18	21:15	Business Wire	Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit	NASDAQ:COYA	Coya Therapeutics Inc
2024/04/08	21:15	Business Wire	Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium	NASDAQ:COYA	Coya Therapeutics Inc
2024/03/19	21:15	Business Wire	Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results	NASDAQ:COYA	Coya Therapeutics Inc
2024/03/12	22:00	Business Wire	Coya Therapeutics to Participate in BTIG Fireside Discussion	NASDAQ:COYA	Coya Therapeutics Inc
2024/03/12	21:00	Business Wire	Coya Therapeutics Presents ALS Biomarker Data at Society of Neuroimmune Pharmacology Conference	NASDAQ:COYA	Coya Therapeutics Inc
2024/03/06	22:15	Business Wire	Coya Therapeutics Presents Biomarker Data on Neuroinflammatory Pathways in Frontotemporal Dementia (FTD) at the AD/PD 2024 Conference	NASDAQ:COYA	Coya Therapeutics Inc
2024/03/06	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COYA	Coya Therapeutics Inc
2024/02/29	22:15	Business Wire	Coya Therapeutics to Present Data on Immune System and Regulatory T Cell (Treg) Contributions in Frontotemporal Dementia (FTD) Patients at AD/PD 2024 Conference	NASDAQ:COYA	Coya Therapeutics Inc
2024/02/22	22:15	Business Wire	Coya Therapeutics to Present Novel Biomarker Survival Data in Large Cohort of ALS (Amyotrophic Lateral Sclerosis) Patients at Society of Neuroimmune Pharmacology Conference	NASDAQ:COYA	Coya Therapeutics Inc
2024/02/21	22:15	Business Wire	Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer’s Disease and Coya’s Pathway to a “Pipeline in a Product”	NASDAQ:COYA	Coya Therapeutics Inc
2024/02/13	22:15	Business Wire	Coya Therapeutics Licenses Intellectual Property Rights for Use of Next Generation Immune Modulatory Biologics in Combination with COYA 301 to Enhance Regulatory T Cells (Tregs) in Inflammatory Diseases	NASDAQ:COYA	Coya Therapeutics Inc
2024/02/03	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COYA	Coya Therapeutics Inc
2024/02/03	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COYA	Coya Therapeutics Inc
2024/01/29	22:15	Business Wire	Coya Therapeutics SAB Chairman Dr. Stanley Appel, M.D. Selected as Speaker at the Society of Neuroimmune Pharmacology Conference	NASDAQ:COYA	Coya Therapeutics Inc
2024/01/20	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COYA	Coya Therapeutics Inc
2024/01/20	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COYA	Coya Therapeutics Inc
2024/01/20	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COYA	Coya Therapeutics Inc
2024/01/19	22:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COYA	Coya Therapeutics Inc
2024/01/18	22:15	Business Wire	Coya Therapeutics to Participate in Upcoming Chardan Biotech Leadership Call Series	NASDAQ:COYA	Coya Therapeutics Inc
2024/01/17	06:06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:COYA	Coya Therapeutics Inc